Patients with metastatic clear cell renal cell carcinoma respond favorably to novel allogeneic CAR T cell therapy.

Published Date: 19 Apr 2023

In patients with metastatic clear cell renal cell carcinoma (ccRCC), the CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, showed encouraging response rates and disease control rates.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New surgical method shows promising results for cervical cancer treatment

2.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

3.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

4.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

5.

Can Prior Authorization Be Better With Artificial Intelligence?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot